Cleared Traditional

K211219 - LASSOSTAR NAV Circular Mapping Catheter

K211219 is the FDA 510(k) clearance for LASSOSTAR NAV Circular Mapping Catheter by Biosense Webster, Inc.. It is a Class 2 Cardiovascular device (product code DRF) cleared through the Traditional 510(k) pathway after a 278-day FDA review.

K211219 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2022
Decision
278d
Days
Class 2
Risk

K211219 is an FDA 510(k) clearance for the LASSOSTAR NAV Circular Mapping Catheter. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Irvine, US). The FDA issued a Cleared decision on January 26, 2022 after a review of 278 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biosense Webster, Inc. devices

Submission Details

510(k) Number K211219 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 2021
Decision Date January 26, 2022
Days to Decision 278 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
153d slower than avg
Panel avg: 125d · This submission: 278d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 97
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K211219.
IntellaMap Orion High Resolution Mapping Catheter
K220796 · Boston Scientific Corporation · Jun 2022
RithmID-SD Steerable Diagnostic Electrophysiology Catheter
K203793 · Synaptic Medical Corporation · Feb 2022
Khelix Steerable Electrophysiology Catheters, Khelix Loop Fixed Electrophysiology Catheters, Khelix Fixed Loop Steerable Electrophysiology Catheters, Khelix Variable Loop Steerable Electrophysiology Catheters
K211327 · CathRx, Ltd. · Feb 2022
ViaCath, AcQRate Dx Steerable Catheter
K212593 · Biotronick, Inc. · Oct 2021
Polaris X Unidirectional Steerable Diagnostic Catheter
K211494 · Boston Scientific Corporation · Sep 2021
Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter
K211375 · Boston Scientific Corporation · Sep 2021